(Q40089993)

17 September 2017

1 reference

title

Neurotransmitter deficits in Alzheimer's disease: criteria for significance (English)

1 reference

17 September 2017

1 reference

1 reference

Greenwald BS

1

1 reference

17 September 2017

Mohs RC

series ordinal

2

1 reference

17 September 2017

Davis KL

series ordinal

3

1 reference

17 September 2017

language of work or name

English

0 references

publication date

1 May 1983

1 reference

Journal of the American Geriatrics Society

17 September 2017

published in

1 reference

17 September 2017

volume

31

1 reference

17 September 2017

issue

5

1 reference

17 September 2017

page(s)

310-316

1 reference

Dementia of the Alzheimer Type

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Neurotransmitter receptor alterations in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Distribution of choline acetyltransferase and glutamate decarboxylase within the substantia nigra and in other brain regions from control and Parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

L-Glutamic Acid Decarboxylase in Parkinson's Disease: Effect of L-Dopa Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Brain glutamic acid decarboxylase activity in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

The pharmacology of tardive dyskinesias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Injected apomorphine and orally administered levodopa in Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

The locus coeruleus: Its possible role in memory consolidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Biochemical mapping of the noradrenergic projection from the locus coeruleus. A model for studies of brain neuronal pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Topographic distribution of neurofibrillary tangles and granulovacuolar degeneration in hippocampal cortex of aging and demented patients. A quantitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Quantitative histological studies on the aged human brain. II. Senile plaques and neurofibrillary tangles in senile dementia (with an appendix on their occurrence in cases of carcinoma).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Changes in the brain catecholamines in patients with dementia of Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Dopamine in Alzheimer's disease and senile dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Pre- and postsynaptic neurochemical alterations in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Noradrenaline in Alzheimer-type dementia and Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Changes in the Monoamine Containing Neurones of the Human Cns in Senile Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Cell loss in the locus coeruleus in senile dementia of Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Brain-decarboxylase activities as indices of pathological change in senile dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Neocortical cholinergic neurons in elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Necropsy evidence of central cholinergic deficits in senile dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Arginine vasopressin and choline acetyltransferase in brains of patients with Alzheimer type senile dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Selective vulnerability of neurones in organic dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Alzheimer-like cholinergic deficiency in Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Selective loss of central cholinergic neurons in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Magnocellular nuclei of the basal forebrain project to neocortex, brain stem, and olfactory bulb. Review of some functional correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Acetylcholinesterase-rich projections from the basal forebrain of the rhesus monkey to neocortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

The ascending cholinergic reticular system: neocortical, olfactory and subcortical projections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

The distribution of septal projections to the hippocampus of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

The cholinergic limbic system: projections to hippocampal formation, medial cortex, nuclei of the ascending cholinergic reticular system, and the subfornical organ and supra-optic crest

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Confirmation from choline acetylase analyses of a massive cholinergic innervation to the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Cholinergic innervation in neuritic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Effect of two weeks' treatment with thioridazine, chlorpromazine, sulpiride and bromazepam, alone or in combination with alcohol, on learning and memory in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Methylphenidate and haloperidol in children. Effects on attention, memory, and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Phenothiazine Effects on Psychological and Psychophysiological Dysfunction in Chronic Schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

The use of trifluoperazine in geriatric patients with chronic brain syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

The value of chemotherapy in senile mental distrubances. Controlled comparison of chlorpromazine, reserpine-pipradrol, and opium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Thiothixene in the treatment of geriatric patients with chronic organic brain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Chlorpromazine in Treatment of Elderly Psychotic Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

HALOPERIDOL IN THE PSYCHIATRIC DISORDERS OF OLD AGE

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Efficacy of antipsychotic medications in behaviorally disturbed dementia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

A new scale for clinical assessment in geriatric populations: Sandoz Clinical Assessment--Geriatric (SCAG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Adverse effects of antihypertensive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Methyldopa-Induced Decrease in Mental Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Letter: Alpha methyldopa and forgetfulness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Letter: Methyldopa and forgetfulness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

An analysis of the learning deficit following hyoscine administration to man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Anterograde amnesic effects of pethidine, hyoscine and diazepam in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Human memory and the cholinergic system. A relationship to aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Memory and cognitive function in man: Does the cholinergic system have a specific role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Letter: Extrapyramidal dementia and levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

L-dopa in senile dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Bromocriptine in presenile dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

The pharmacology of memory: a neurobiological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Clinical experience with L-glutavite in aged patients with behavior problems and memory defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Physostigmine: Improvement of Long-Term Memory Processes in Normal Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Human Serial Learning: Enhancement with Arecholine and Choline Impairment with Scopolamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Effects of physostigmine and lecithin on memory in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Effect of Physostigmine on Constructional and Memory Tasks in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Physostigmine in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Clinical effects of choline in Alzheimer senile dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Influence of choline on amnesia in early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Choline therapy in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Long-term choline treatment of memory-impaired elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Lecithin in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Memory decline in the aged: treatment with lecithin and physostigmine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Physostigmine and its effect on six patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Physostigmine and Recent Memory: Effects in Young and Aged Nonhuman Primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Memory deficits in aged cebus monkeys and facilitation with central cholinomimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Physostigmine and arecoline: effects of intravenous infusions in Alzheimer presenile dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

Clinical Response to Choline plus Piracetam in Senile Dementia: Relation to Red-Cell Choline Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1983.TB04877.X

10.1111/J.1532-5415.1983.TB04877.X

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference